SCHEMBL21687970

SCHEMBL21687970

N#Cc1cc(-c2ccccc2-n2c3ccccc3c3ccccc32)ccc1[Si](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.33
KDM4E B2RXH2 2/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TRPA1 O75762 1/20 0.33
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
HIF1A Q16665 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
IMPDH2 P12268 1/20 0.31
NR3C1 P04150 1/20 0.31
AR P10275 1/20 0.31
HTT P42858 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
LMNA P02545 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687497 0.93 PTGER4 (0.33) NR3C1
SCHEMBL21687733 0.92 SMN1; SMN2 (0.40) ALDH1A1L3MBTL1TRPA1ALOX5APFEN1
SCHEMBL21687628 0.91 CYP11B2 (0.34) ALDH1A1KDM4EATML3MBTL1TRPA1
SCHEMBL21688108 0.89 KDM4E (0.34) ALDH1A1KDM4EATML3MBTL1CYP11B1
SCHEMBL21688042 0.89 ALDH1A1 (0.34) ALDH1A1KDM4EATML3MBTL1SMN1; SMN2
SCHEMBL21688232 0.89 GABRA1 (0.34) ATMCYP11B1CYP11B2SMN1; SMN2HIF1A
SCHEMBL21688043 0.89 PTGER4 (0.31) KDM4EATML3MBTL1ALOX5APFEN1
SCHEMBL21687700 0.89 NR3C1 (0.31) ALDH1A1KDM4EALOX5APFEN1SMN1; SMN2
SCHEMBL21687460 0.88 ESR2 (0.35) ALDH1A1KDM4EATML3MBTL1TRPA1
SCHEMBL21687609 0.87 ALDH1A1 (0.34) ALDH1A1KDM4EATML3MBTL1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 ALDH1A1 616/4885KDM4E 2977/4885ATM 1151/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 ALDH1A1 616/4885KDM4E 2977/4885ATM 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.